Core Insights - Southern Michigan Bancorp, Inc. reported a net income of $3,019,000 for Q3 2025, representing a 16.70% increase from $2,586,000 in Q3 2024 [1] - For the first nine months of 2025, net income reached $9,303,000, a 20.0% increase compared to $7,751,000 in the same period of 2024 [1] Financial Performance - The annualized return on average assets improved to 0.79% for the nine months ended September 30, 2025, up from 0.70% for the same period in 2024 [2] - The annualized return on average equity increased to 11.00% in the first nine months of 2025, compared to 10.18% in the first nine months of 2024 [2] - The tax equivalent net interest margin rose to 3.21% for the nine-month period ending September 30, 2025, compared to 2.94% for the same period in 2024 [2] Operational Highlights - The company achieved record levels in loans, deposits, and total assets by the end of the quarter, as stated by the CEO [3] - The allowance for credit losses was $14,410,000, or 1.17% of loans, as of September 30, 2025 [3] - Non-performing loans as a percentage of total loans increased to 1.03% as of September 30, 2025, from 0.08% as of December 31, 2024 [3] Balance Sheet Overview - Total assets reached $1,665,097,000 as of September 30, 2025, compared to $1,496,555,000 as of December 31, 2024 [6][7] - Total deposits increased to $1,394,932,000 in September 2025, up from $1,251,795,000 in December 2024 [7] - Shareholders' equity rose to $117,778,000 as of September 30, 2025, compared to $107,223,000 at the end of 2024 [7] Income Statement Summary - Total interest income for Q3 2025 was $21,269,000, compared to $19,531,000 in Q3 2024 [8][9] - Net interest income after provision for credit losses was $10,886,000 for Q3 2025, up from $9,968,000 in Q3 2024 [9] - Non-interest income totaled $2,618,000 for Q3 2025, compared to $2,172,000 in Q3 2024 [9]

Michael Jacobs, President Americas & Asia Pacific, GXO GXO appoints Michael Jacobs as President, Americas & Asia Pacific Appoints new leader of Americas & Asia Pacific; Simplifies management structure; Strengthens Execution GREENWICH, Conn., Oct. 29, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced organizational changes to accelerate growth, simplify its structure, and strengthen execution. GXO CEO Patrick Kelleher sa ...

WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in three upcoming healthcare conferences in November. On Wednesday November 12, 2025, at 11:00 AM EST, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during t ...

The acquisition is non-dilutive for shareholders and expected to generate over $30 million in annual premiums, with $8 million in annual revenues over the next twelve months after closing, and a 25% net income margin on a standalone basisNEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN), a global leader in AI at the intersection of insurance and mobility, today announced that it has signed a definitive agreement to acquire majority control of a commercial auto insurance broker and mana ...

Q3-2025 Net Income of $6.7 million, EBITDA1 of $18.7 million and Free Cash Flow to Equity1 of $11.1 millionFull Debt Repayment Achieved in October 2025Quarterly dividend Increased by 33%Quarterly Dividend of Cdn$0.04 Declared VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce a strong financial performance for the three months ended September 30, 2025 (“Q3-2025”) and the full repayment of corporat ...

CELEBRATION, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will participate in a fireside discussion at Guggenheim's 2nd Annual Healthcare Innovation Conference in Boston, MA on Wednesday, November 12, 2025, at 11:30 a.m. ET. Additionally, management will be available for one-on-one meetin ...

BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 1 ...

Vancouver, BC, Oct. 29, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (“First American Uranium”, or the “Company”) is pleased to announce the successful completion of a site visit to its Seigneurie Property, located in the Regional County Municipality of La Haute-Côte-Nord in Quebec’s Grenville Proterozoic Province. The visit was conducted on October 22, 2025, by Murray Nye, Chief Executive Officer and Clyde McMillan, Technical Advisor. Purpose and Key Findings Th ...

WINSTON-SALEM, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the following two upcoming healthcare conferences in November: Guggenheim Healthcare Innovation Conference (Boston)Date: Wednesday, November 12, 2025Time: 10:00am ETFormat: Fireside ChatWebcast: Link Jefferies ...

JUPITER, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression platforms, today announced that it will report its financial results for the sec ...